Uri A. Lopatin - Feb 1, 2022 Form 4 Insider Report for PARDES BIOSCIENCES, INC. (PRDS)

Role: President and CEO, Director
Signature: /s/ Elizabeth Lacy, attorney-in-fact
Stock symbol: PRDS
Transactions as of: Feb 1, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/2/2022, 06:03 PM
Previous filing: Dec 27, 2021
Next filing: Jun 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRDS	Stock Option (Right to Buy)	Award	$0	+421K		$0.00	421K	Feb 1, 2022	Common Stock	421K	$11.32	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option shall vest in substantially equal monthly installments over four years from February 1, 2022, subject to a continued service relationship. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2021 Stock Option and Incentive Plan with the U.S. Securities and Exchange Commission.

Content

This option shall vest in substantially equal monthly installments over four years from February 1, 2022, subject to a continued service relationship. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2021 Stock Option and Incentive Plan with the U.S. Securities and Exchange Commission.